Company intelligence
Inpart
An online platform for scientific partnering helping take discoveries from bench to bedside.
About Inpart
Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to initiate, optimize, and manage collaborations across industry and academia. In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry. The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations. Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.
Verified activity
Signals from Inpart
3 published signals
Presence & Recognition
Inpart hosted a new webinar titled Centralizing Alliance Management with Novo Nordisk on Thursday, October 15th, 4pm CET.
Reported by Inpart
Products & Services
Inpart built a pipeline calculator to give any top 20 pharma BD team a personalised cost breakdown across pipeline reporting, submission screening, duplicate reviews, cross-functional evaluation, and annual overhead in hours and cost.
Reported by Inpart
Research & Knowledge
Inpart published the Digital Maturity Calculator for the pharma alliance, which shows that the peer average is 16.2 out of 30.
Reported by Inpart